Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 studyYehuda Z. Cohen, Marina Caskey, Allison L. Butler et al.|PLoS ONE|2019Cited by 92
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionalityWilliam R. Morgenlander, H. Benjamin Larman, Eric Fujimura et al.|Journal of Clinical Investigation|2021Cited by 87
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent PlasmaHarini Natarajan, Margaret E. Ackerman, Andrew R. Crowley et al.|mBio|2021Cited by 83